Richard Narido
Director of Finance/CFO presso NRX PHARMACEUTICALS, INC.
Profilo
Richard Narido is currently the Chief Financial & Accounting Officer at NRX Pharmaceuticals, Inc. He previously worked as the Vice President-Finance at Lucira Health, Inc. from 2021 to 2022.
Mr. Narido has an undergraduate degree from the University of San Francisco and a graduate degree from Pepperdine Graziadio Business School.
Posizioni attive di Richard Narido
Società | Posizione | Inizio |
---|---|---|
NRX PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/09/2023 |
Precedenti posizioni note di Richard Narido
Società | Posizione | Fine |
---|---|---|
LUCIRA HEALTH, INC. | Director of Finance/CFO | 01/04/2023 |
Formazione di Richard Narido
University of San Francisco | Undergraduate Degree |
Pepperdine Graziadio Business School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NRX PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Lucira Health, Inc.
Lucira Health, Inc. Medical SpecialtiesHealth Technology Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. It operates through the following customer segments: the United States Healthcare (US Healthcare), United States Business to Business and Government (US Business to Business and Government), Direct to Consumer (DTC), and International. The US Healthcare segment provides solutions of choice for certain telehealth platforms and providers who are able to confirm diagnosis immediately and over a telehealth platform to drive treatment. The US Business to Business and Government segment is involved in selling OTC test kits to both employers and government organizations. The DTC segment includes selling directly to the individual consumer through online platforms. The International segment focuses on selling tests into Canada, Taiwan, Singapore, and Israel. The company was founded by Debkishore Mitra, John Robert Waldeisen, and Benjamin Ross on February 20, 2013 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Richard Narido